Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|HER2/Neu Positive|Geriatric Health Services
Interventions: DRUG: Lapatinib|DRUG: Trastuzumab|OTHER: laboratory biomarker analysis|OTHER: pharmacological study
Sponsor: City of Hope Medical Center
Collaborators: GlaxoSmithKline|Novartis